US 100% Tariff on Patented Drugs: Impact on India
Why in the news
The United States, under Donald Trump, announced a 100% tariff on patented medicines and APIs. Indian drug exporters were flagged as likely to feel the impact.
Key facts
- Rate: 100% tariff.
- Items covered: patented drugs and APIs (the active ingredients used to make medicines).
- Route: an executive order announced by Donald Trump.
- Objective: encourage drug manufacturing within the US.
Significance
- Expected to hit India’s pharmaceutical exports in a big way.
- Seen as another sign of protectionism spreading in global trade.
Exam angle
- Question stem to expect: tariff percentage on patented pharmaceuticals, which is 100%.
- Instrument used: an executive order, not a law passed by a legislature.
- Related term: protectionism, trade policy that favours home producers.